Unknown OBSERVATIONAL NCT00407706

Using Test of SCM for Detection Breast Cancer

Breast Cancer- Early Detection of Cancer Disease and Pre-Cancer Disease, and in Women That Are at High Risk for Developing Breast Cancer by Identifying Lymphocytes Previously Exposed to Specific Cancer Antigen.

Sponsor: Ziv Hospital

Conditions Malignant Breast Cancer, Benign Breast Lesions

Interventions blood test

Updated 5 times since 2017 Last updated: Dec 4, 2006 Started: Dec 31, 2006 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Malignant Breast Cancer, Benign Breast Lesions and is currently ongoing. Ziv Hospital leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ziv Hospital

Data source: Ziv Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Safed, Israel